Bharat Biotech Declared The Vaccine Or Dreadful Diseases Will Be Launched By July 2021

Administrators of Bharat Biotech have revealed that coronavirus vaccine candidate Covaxin is expected to be ready by June 2021. On Thursday, the Drug Controller General of India (DGCI) allowed Bharat Biotech International Limited to conduct the Phase III trials of its Covid-19 vaccine candidate Covaxin.

Covaxin expected to be ready by June 2021

According to a report by the Indian Express, a top company official informed that Covaxin should be ready by June 2021- unless the government expands its launch through emergency use authorization.

"If we get all the approvals in place, I think during Quarantine 2 of 2021, we should get the efficacy readout from our phase-3 clinical trial — April, May, June, for example. That is for the full efficacy results," Sai Prasad, executive director, Bharat Biotech International Ltd, in his interview by Indian Express. It is developed by Bharat Biotech along with the Indian Council of Medical Research and National Institute of Virology, Covaxin is India's first indigenous vaccine candidate against the Covid-19.

The official further said, "We are committed to doing all our phase-1, phase-2, and phase-3 clinical trials in its entirety, but I think the government may also be considering emergency use approval".

Bharat Biotech to conduct trials on 26,000 people in 25 centers

Bharat Biotech will be conducting Phase 3 trials for its Covid-19 vaccine candidate, COVAXIN, in 25 centers across India and a total of 26,000 people will be participating in the Phase 3 trials.

Zydus Cadila, which is close to completing phase-2 trials of ZyCov-D, Russia’s Gamaleya Research Institute, which will soon begin phase 2/3 trials of Sputnik V in collaboration with Dr. Reddy’s and Serum Institute of India's Covishield are other coronavirus vaccine candidates in the fray.

DISCLAIMER 

The content of this site, like text, graphic, and images are intended for informational purpose. It is not intended to be misled. Although, authors have made his / her efforts to bring the truth and facts. He /she is not credible for any kind of loss or harm.